Cargando…
Validation of Neurotensin Receptor 1 as a Therapeutic Target for Gastric Cancer
Gastric cancer is the fifth most common type of malignancy worldwide, and the survival rate of patients with advanced-stage gastric cancer is low, even after receiving chemotherapy. Here, we validated neurotensin receptor 1 (NTSR1) as a potential therapeutic target in gastric cancer. We compared NTS...
Autores principales: | Akter, Hafeza, Yoon, Jung Hwan, Yoo, Young Sook, Kang, Min-Jung |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Society for Molecular and Cellular Biology
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6030244/ https://www.ncbi.nlm.nih.gov/pubmed/29794962 http://dx.doi.org/10.14348/molcells.2018.0025 |
Ejemplares similares
-
Imaging Neurotensin Receptor in Prostate Cancer With (64)Cu-Labeled Neurotensin Analogs
por: Deng, Huaifu, et al.
Publicado: (2017) -
Design, Synthesis,
and Biological Evaluation of the
First Radio-Metalated Neurotensin Analogue Targeting Neurotensin Receptor
2
por: Bodin, Sacha, et al.
Publicado: (2023) -
Thermostabilisation of the neurotensin receptor NTS1
por: Shibata, Yoko, et al.
Publicado: (2009) -
Neurotensin-induced miR-133α expression regulates neurotensin receptor 1 recycling through its downstream target aftiphilin
por: Law, Ivy Ka Man, et al.
Publicado: (2016) -
Structure of the agonist-bound neurotensin receptor
por: White, Jim F., et al.
Publicado: (2012)